Of note, older patients with EBV-associated DLBCL and CD30 expression have a very poor outcome [9]; however, rituximab-combined immunochemotherapy successfully eradicated the EBV-infected cells in our patient, as shown by the EBV DNA level. The gene discussed is TNFRSF8; the disease is diffuse large B-cell lymphoma.